Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Stephanie A. Harmon, Esther Mena, Joanna H. Shih, Stephen Adler, Yolanda McKinney, Ethan Bergvall, Sherif Mehralivand, Adam G. Sowalsky, Anna Couvillon, Ravi A. Madan, James L. Gulley, Janet Eary, Ronnie C. Mease, Martin G. Pomper, William L. Dahut, Baris Turkbey, Liza Lindenberg, Peter L. Choyke
Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37676-37688
Karine Pozo, Stefan Zahler, Keisuke Ishimatsu, Angela M. Carter, Rahul Telange, Chunfeng Tan, Shuaijun Wang, Roswitha Pfragner, Junya Fujimoto, Elizabeth Gardner Grubbs, Masaya Takahashi, Sarah C. Oltmann, James A. Bibb
Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37662-37675
Roberto Carmagnani Pestana, Manal M. Hassan, Reham Abdel-Wahab, Yehia I. Abugabal, Lauren M. Girard, Donghui Li, Ping Chang, Kanwal Raghav, Jeff Morris, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed Kaseb
Published Dec 28, 2018 · Vol. 9, No. 102 · pp. 37721-37732